95 related articles for article (PubMed ID: 3429067)
1. Theophylline disposition after single-dose ingestion of a once-a-day preparation (Dilatrane A. P. 400 mg) with and without breakfast.
Jonkman JH; Grasmeijer G; Holland A
Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):633-7. PubMed ID: 3429067
[TBL] [Abstract][Full Text] [Related]
2. The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations.
Pargal A; Kelkar MG; Nayak PJ
Biopharm Drug Dispos; 1996 Aug; 17(6):511-9. PubMed ID: 8866042
[TBL] [Abstract][Full Text] [Related]
3. Single dose study of the bioequivalence of two sustained-release theophylline formulations.
Contreras J; Pérez N; González R; Ontivero E; López M
Arzneimittelforschung; 1998 Mar; 48(3):259-62. PubMed ID: 9553683
[TBL] [Abstract][Full Text] [Related]
4. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
[TBL] [Abstract][Full Text] [Related]
5. Influence of morning or evening administration on absorption of theophylline.
Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
[TBL] [Abstract][Full Text] [Related]
6. Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs.
Matsuda K; Takaya T; Shimoji F; Muraoka M; Yoshikawa Y; Takada K
J Drug Target; 1996; 4(2):59-67. PubMed ID: 8894965
[TBL] [Abstract][Full Text] [Related]
7. Effect of an enteral nutrient formula on sustained-release theophylline absorption.
Bhargava VO; Schaaf LJ; Berlinger WG; Jungnickel PW
Ther Drug Monit; 1989 Sep; 11(5):515-9. PubMed ID: 2510372
[TBL] [Abstract][Full Text] [Related]
8. Influence of food on the bioavailability of theophylline from a sustained-released theophylline preparation.
Lohmann A; Dingler E; Sommer W
Arzneimittelforschung; 1991 Jul; 41(7):732-4. PubMed ID: 1772462
[TBL] [Abstract][Full Text] [Related]
9. Influence of food intake on the bioavailability of urapidil in healthy volunteers.
Kirsten R; Nelson K; Molz KH; Gielsdorf W; Haerlin R
Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):298-301. PubMed ID: 2737799
[TBL] [Abstract][Full Text] [Related]
10. Influence of food on steady state serum concentrations of theophylline from two controlled-release preparations.
Lefebvre RA; Belpaire FM; Bogaert MG
Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):375-9. PubMed ID: 3220610
[TBL] [Abstract][Full Text] [Related]
11. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
Götz J; Sauter R; Steinijans VW; Jonkman JH
Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the bioavailability and pharmacokinetic profile of a theophylline pellet formulation designed for once-daily dosage with a pellet preparation designed for twice-daily dosage].
Keinke O
Arzneimittelforschung; 1989 Nov; 39(11):1460-4. PubMed ID: 2619780
[TBL] [Abstract][Full Text] [Related]
13. Single dose bioavailability of two different digoxin tablets.
Jonkman JH; Gusdorf CF; van der Boon WJ; Grasmeijer G; Jedema JN
Arzneimittelforschung; 1987 Jan; 37(1):62-5. PubMed ID: 3566859
[TBL] [Abstract][Full Text] [Related]
14. [Absorption profile and absolute bioavailability of a theophylline--retard preparation].
Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
Arzneimittelforschung; 1990 Nov; 40(11):1218-24. PubMed ID: 2085333
[TBL] [Abstract][Full Text] [Related]
15. Study on the influence of food on the absorption of theophylline from a controlled-release preparation.
Pabst G; Weber W; Müller M; Barkworth MF
Arzneimittelforschung; 1994 Mar; 44(3):333-7. PubMed ID: 8192698
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
[TBL] [Abstract][Full Text] [Related]
17. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics of theophylline in sustained-release formulation in young asthmatics].
Witschital K; Fuchs WS; Heese U; von Nieciecki A; Laicher A
Arzneimittelforschung; 1998 May; 48(5A):593-6. PubMed ID: 9676351
[TBL] [Abstract][Full Text] [Related]
20. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]